968 related articles for article (PubMed ID: 17605616)
1. Characterization of protection against systemic infection and disease from experimental bovine viral diarrhea virus type 2 infection by use of a modified-live noncytopathic type 1 vaccine in calves.
Kelling CL; Hunsaker BD; Steffen DJ; Topliff CL; Eskridge KM
Am J Vet Res; 2007 Jul; 68(7):788-96. PubMed ID: 17605616
[TBL] [Abstract][Full Text] [Related]
2. Characterization of protection from systemic infection and disease by use of a modified-live noncytopathic bovine viral diarrhea virus type 1 vaccine in experimentally infected calves.
Kelling CL; Hunsaker BD; Steffen DJ; Topliff CL; Abdelmagid OY; Eskridge KM
Am J Vet Res; 2005 Oct; 66(10):1785-91. PubMed ID: 16273912
[TBL] [Abstract][Full Text] [Related]
3. Effects of modified-live bovine viral diarrhea virus vaccines containing either type 1 or types 1 and 2 BVDV on heifers and their offspring after challenge with noncytopathic type 2 BVDV during gestation.
Ficken MD; Ellsworth MA; Tucker CM; Cortese VS
J Am Vet Med Assoc; 2006 May; 228(10):1559-64. PubMed ID: 16677126
[TBL] [Abstract][Full Text] [Related]
4. Vaccination with a modified-live bovine viral diarrhea virus (BVDV) type 1a vaccine completely protected calves against challenge with BVDV type 1b strains.
Xue W; Mattick D; Smith L; Umbaugh J; Trigo E
Vaccine; 2010 Dec; 29(1):70-6. PubMed ID: 21034829
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of a modified live virus type-1a bovine viral diarrhea virus vaccine (Singer strain) against a type-2 (strain 890) challenge.
Fairbanks K; Schnackel J; Chase CC
Vet Ther; 2003; 4(1):24-34. PubMed ID: 12756633
[TBL] [Abstract][Full Text] [Related]
6. Immunogenicity of a modified-live virus vaccine against bovine viral diarrhea virus types 1 and 2, infectious bovine rhinotracheitis virus, bovine parainfluenza-3 virus, and bovine respiratory syncytial virus when administered intranasally in young calves.
Xue W; Ellis J; Mattick D; Smith L; Brady R; Trigo E
Vaccine; 2010 May; 28(22):3784-92. PubMed ID: 20381643
[TBL] [Abstract][Full Text] [Related]
7. Protection against fetal infection with either bovine viral diarrhea virus type 1 or type 2 using a noncytopathic type 1 modified-live virus vaccine.
Brock KV; McCarty K; Chase CC; Harland R
Vet Ther; 2006; 7(1):27-34. PubMed ID: 16598681
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the efficacy of a modified-live combination vaccine against bovine viral diarrhea virus types 1 and 2 challenge exposures in a one-year duration-of-immunity fetal protection study.
Ficken MD; Ellsworth MA; Tucker CM
Vet Ther; 2006; 7(3):283-94. PubMed ID: 17039451
[TBL] [Abstract][Full Text] [Related]
9. Protection of pregnant cattle and their fetuses against infection with bovine viral diarrhea virus type 1 by use of a modified-live virus vaccine.
Cortese VS; Grooms DL; Ellis J; Bolin SR; Ridpath JF; Brock KV
Am J Vet Res; 1998 Nov; 59(11):1409-13. PubMed ID: 9829398
[TBL] [Abstract][Full Text] [Related]
10. [Vaccination of calves with contaminated batches of bovine herpes virus 1 vaccines did not result in infection with bovine virus diarrhea virus].
Antonis AF; van Oirschot JT; van Es M; Bruschke CJ
Tijdschr Diergeneeskd; 2001 Mar; 126(6):208-11. PubMed ID: 11285641
[TBL] [Abstract][Full Text] [Related]
11. Associations between health and productivity in cow-calf beef herds and persistent infection with bovine viral diarrhea virus, antibodies against bovine viral diarrhea virus, or antibodies against infectious bovine rhinotracheitis virus in calves.
Waldner CL; Kennedy RI
Am J Vet Res; 2008 Jul; 69(7):916-27. PubMed ID: 18593246
[TBL] [Abstract][Full Text] [Related]
12. Protection from persistent infection with a bovine viral diarrhea virus (BVDV) type 1b strain by a modified-live vaccine containing BVDV types 1a and 2, infectious bovine rhinotracheitis virus, parainfluenza 3 virus and bovine respiratory syncytial virus.
Xue W; Mattick D; Smith L
Vaccine; 2011 Jun; 29(29-30):4657-62. PubMed ID: 21596076
[TBL] [Abstract][Full Text] [Related]
13. One year duration of immunity of the modified live bovine viral diarrhea virus type 1 and type 2 and bovine herpesvirus-1 fractions of Vista® Once SQ vaccine.
Purtle L; Mattick D; Schneider C; Smith L; Xue W; Trigo E
Vaccine; 2016 Mar; 34(13):1582-1588. PubMed ID: 26859238
[TBL] [Abstract][Full Text] [Related]
14. Transmission of bovine viral diarrhea virus 1b to susceptible and vaccinated calves by exposure to persistently infected calves.
Fulton RW; Briggs RE; Ridpath JF; Saliki JT; Confer AW; Payton ME; Duff GC; Step DL; Walker DA
Can J Vet Res; 2005 Jul; 69(3):161-9. PubMed ID: 16187545
[TBL] [Abstract][Full Text] [Related]
15. Induction of antigen-specific T-cell subset activation to bovine respiratory disease viruses by a modified-live virus vaccine.
Platt R; Burdett W; Roth JA
Am J Vet Res; 2006 Jul; 67(7):1179-84. PubMed ID: 16817740
[TBL] [Abstract][Full Text] [Related]
16. Use of a modified-live vaccine to prevent persistent testicular infection with bovine viral diarrhea virus.
Givens MD; Riddell KP; Zhang Y; Galik PK; Stringfellow DA; Brodersen BW; Jackson JA; Ellsworth MA; Ficken MD; Carson RL; Wenzel JG; Marley MS
Vet Ther; 2006; 7(3):305-18. PubMed ID: 17039453
[TBL] [Abstract][Full Text] [Related]
17. Immunogenicity of an inactivated Chinese bovine viral diarrhea virus 1a (BVDV 1a) vaccine cross protects from BVDV 1b infection in young calves.
Wang W; Shi X; Wu Y; Li X; Ji Y; Meng Q; Zhang S; Wu H
Vet Immunol Immunopathol; 2014 Aug; 160(3-4):288-92. PubMed ID: 24880701
[TBL] [Abstract][Full Text] [Related]
18. Comparison of three commercial vaccines for preventing persistent infection with bovine viral diarrhea virus.
Rodning SP; Marley MS; Zhang Y; Eason AB; Nunley CL; Walz PH; Riddell KP; Galik PK; Brodersen BW; Givens MD
Theriogenology; 2010 May; 73(8):1154-63. PubMed ID: 20181385
[TBL] [Abstract][Full Text] [Related]
19. Humoral and T cell-mediated immune responses to bivalent killed bovine viral diarrhea virus vaccine in beef cattle.
Platt R; Coutu C; Meinert T; Roth JA
Vet Immunol Immunopathol; 2008 Mar; 122(1-2):8-15. PubMed ID: 18190971
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of multiple immune parameters after vaccination with modified live or killed bovine viral diarrhea virus vaccines.
Reber AJ; Tanner M; Okinaga T; Woolums AR; Williams S; Ensley DT; Hurley DJ
Comp Immunol Microbiol Infect Dis; 2006 Jan; 29(1):61-77. PubMed ID: 16543046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
